Bionews Staff,  writers and editors—

Bacterial infections pose a major health risk in cystic fibrosis patents, which can lead to hospitalization and life-threatening health issues. As a result, the research community continues to focus on new therapies that effectively treat CF patients for common bacterial infections in the lungs while also facilitating patient compliance.

Increasingly in the cystic fibrosis community, fundraising walking and running events have become a popular, effective means of raising awareness about the disease and supporting ongoing research efforts to bolster drug development for next-generation CF treatments. No other group has utilized this sort of fundraising event better than the…